Vivos Therapeutics (VVOS) Q2 2026 Earnings Call: Revenue Up 35%, Liquidity Risks Persist
Source Tradingkey
Key Takeaways
- Second-quarter revenue rose 35% year over year to $5.2 million, driven by Sleep Center of Nevada (SCN) diagnostic services and treatment revenue at Vivos centers.
- Gross profit increased by $800,000 to $3.0 million, with a reported gross margin of 57%. The quarterly net loss widened to $5.5 million from $5.0 million.
- Service revenue increased by $1.9 million, including $1.5 million from sleep testing services and $800,000 from Vivos patient treatments launched at two SCN locations.
- Vivos ended June 30, 2026, with $1.8 million in cash and cash equivalents, $28.1 million in total liabilities and an accumulated deficit of $138 million. The company said existing cash is insufficient to fund the next 12 months.
- Management sees a potential path to positive cash flow near the end of 2026 or in early 2027, subject to implementation, patient enrollment, reimbursement, capacity and operating execution.
- Vivos is not currently compliant with Nasdaq’s $2.5 million minimum stockholders’ equity requirement and is seeking additional equity funding while reducing costs.
Core Financial Data
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $5.2M | $3.8M | +35% |
| Cost of sales | $2.2M | $1.7M | +29% |
| Gross profit | $3.0M | $2.2M | +$0.8M |
| Gross margin | 57% | — | — |
| General and administrative expenses | $7.1M | $6.4M | +11% |
| Sales and marketing expenses | $0.2M | $0.3M | -$0.1M |
| Net loss | $5.5M | $5.0M | Loss widened by $0.5M |
| Metric | H1 2026 | H1 2025 | Change |
|---|---|---|---|
| Revenue | $10.3M | $6.8M | +51% |
| Gross profit | $6.0M | $3.6M | +$2.4M |
| Gross margin | 58% | 53% | +5 percentage points |
| Net loss | $13.3M | $8.9M | Loss widened by $4.4M |
| Operating cash used | $9.2M | $7.3M | +$1.9M |
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Recommended Articles
Alphabet (GOOGL) stock climbed about 3% on Monday. The trigger was a report from The Information that Google is building a new AI chip, called Frozen v2, to run its Gemini models up to 10 times more e
Elon Musk offered a blunt reaction to the AI safety debate early Sunday. He wrote that he hopes AI is nice to us, echoing a stark warning from investor Naval Ravikant.The post landed just a minute aft
Bitcoin (BTC) trades at half its record price. XRP (XRP) has lost roughly 73% from its own peak. Four events this week could decide whether either one escapes that range.Both drifted lower again over
Global bond yields have reached levels last seen in July 2008. Bitcoin (BTC) did not exist then. The asset has never traded through borrowing costs this high, and it is not benefiting now.Gold rose 32
Weekly Market Wrap: US CPI lifted markets, but oil and chip volatility kept risks aliveUS CPI helped lift global markets this week, but sharp moves in oil and semiconductor stocks kept volatility elevated. Get the latest weekly market wrap, key drivers, major risks and what traders should watch next across stocks, commodities and currencies.
US CPI helped lift global markets this week, but sharp moves in oil and semiconductor stocks kept volatility elevated. Get the latest weekly market wrap, key drivers, major risks and what traders should watch next across stocks, commodities and currencies.
